このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
WuXi Biologics (Cayman) バランスシートの健全性
財務の健全性 基準チェック /56
WuXi Biologics (Cayman)の総株主資本はCN¥44.0B 、総負債はCN¥2.1Bで、負債比率は4.9%となります。総資産と総負債はそれぞれCN¥56.6BとCN¥12.6Bです。 WuXi Biologics (Cayman)の EBIT はCN¥3.9Bで、利息カバレッジ比率-64.8です。現金および短期投資はCN¥11.2Bです。
主要情報
4.9%
負債資本比率
CN¥2.15b
負債
| インタレスト・カバレッジ・レシオ | -64.8x |
| 現金 | CN¥11.24b |
| エクイティ | CN¥44.02b |
| 負債合計 | CN¥12.56b |
| 総資産 | CN¥56.58b |
財務の健全性に関する最新情報
Here's Why WuXi Biologics (Cayman) (HKG:2269) Can Manage Its Debt Responsibly
Apr 15
Does WuXi Biologics (Cayman) (HKG:2269) Have A Healthy Balance Sheet?
Nov 26These 4 Measures Indicate That WuXi Biologics (Cayman) (HKG:2269) Is Using Debt Reasonably Well
Aug 26Does WuXi Biologics (Cayman) (HKG:2269) Have A Healthy Balance Sheet?
Mar 25Is WuXi Biologics (Cayman) (HKG:2269) A Risky Investment?
Dec 09WuXi Biologics (Cayman) (HKG:2269) Seems To Use Debt Quite Sensibly
Sep 08Recent updates
Shareholders May Not Be So Generous With WuXi Biologics (Cayman) Inc.'s (HKG:2269) CEO Compensation And Here's Why
Jun 12Some Confidence Is Lacking In WuXi Biologics (Cayman) Inc. (HKG:2269) As Shares Slide 25%
Jun 11Some WuXi Biologics (Cayman) Inc. (HKG:2269) Shareholders Look For Exit As Shares Take 25% Pounding
Jun 11Here's Why WuXi Biologics (Cayman) (HKG:2269) Can Manage Its Debt Responsibly
Apr 15Why Investors Shouldn't Be Surprised By WuXi Biologics (Cayman) Inc.'s (HKG:2269) 25% Share Price Surge
Mar 04Things Look Grim For WuXi Biologics (Cayman) Inc. (HKG:2269) After Today's Downgrade
Dec 08Does WuXi Biologics (Cayman) (HKG:2269) Have A Healthy Balance Sheet?
Nov 26Estimating The Fair Value Of WuXi Biologics (Cayman) Inc. (HKG:2269)
Nov 10What Does WuXi Biologics (Cayman) Inc.'s (HKG:2269) Share Price Indicate?
Sep 26These 4 Measures Indicate That WuXi Biologics (Cayman) (HKG:2269) Is Using Debt Reasonably Well
Aug 26WuXi Biologics (Cayman) Inc. (HKG:2269) Shares Could Be 24% Below Their Intrinsic Value Estimate
Aug 10Is WuXi Biologics (Cayman) Inc. (HKG:2269) Potentially Undervalued?
Jun 19Estimating The Fair Value Of WuXi Biologics (Cayman) Inc. (HKG:2269)
May 12Does WuXi Biologics (Cayman) (HKG:2269) Have A Healthy Balance Sheet?
Mar 25At HK$52.00, Is WuXi Biologics (Cayman) Inc. (HKG:2269) Worth Looking At Closely?
Mar 13Does WuXi Biologics (Cayman) (HKG:2269) Deserve A Spot On Your Watchlist?
Feb 13An Intrinsic Calculation For WuXi Biologics (Cayman) Inc. (HKG:2269) Suggests It's 29% Undervalued
Jan 30Is WuXi Biologics (Cayman) (HKG:2269) A Risky Investment?
Dec 09Why WuXi Biologics (Cayman) Inc. (HKG:2269) Could Be Worth Watching
Nov 20With EPS Growth And More, WuXi Biologics (Cayman) (HKG:2269) Makes An Interesting Case
Nov 08Is WuXi Biologics (Cayman) Inc. (HKG:2269) Trading At A 47% Discount?
Oct 27WuXi Biologics (Cayman) (HKG:2269) Seems To Use Debt Quite Sensibly
Sep 08Is Now The Time To Look At Buying WuXi Biologics (Cayman) Inc. (HKG:2269)?
Aug 15We Ran A Stock Scan For Earnings Growth And WuXi Biologics (Cayman) (HKG:2269) Passed With Ease
Aug 02Estimating The Intrinsic Value Of WuXi Biologics (Cayman) Inc. (HKG:2269)
Jun 29What Does WuXi Biologics (Cayman) Inc.'s (HKG:2269) Share Price Indicate?
May 16Here's Why I Think WuXi Biologics (Cayman) (HKG:2269) Might Deserve Your Attention Today
May 03財務状況分析
短期負債: 2269の 短期資産 ( CN¥21.2B ) が 短期負債 ( CN¥7.6B ) を超えています。
長期負債: 2269の短期資産 ( CN¥21.2B ) が 長期負債 ( CN¥4.9B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 2269総負債よりも多くの現金を保有しています。
負債の削減: 2269の負債対資本比率は、過去 5 年間で0%から4.9%に増加しました。
債務返済能力: 2269の負債は 営業キャッシュフロー によって 十分にカバー されています ( 217.4% )。
インタレストカバレッジ: 2269支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。